Consortium invests SEK 10m in Promimic

ALMI Invest provided the bulk of the funding from its ALMI Invest Västsverige Fund. The investors were attracted to the deal after a number of successful pre-clinical tests.

Funding will support a more aggressive expansion strategy, with increased international market presence.

Company
Promimic is based in Gothenburg and is a biomaterial company that develops and markets an implant surface which is said to accelerate osseointegration. The company's product, HANANO, is based on nanotechnology.

KEY FACTS

Promimic AB

DEAL TYPE – Expansion
DEAL VALUE – SEK 10m
LOCATION – Gothenburg
SECTOR – Biotechnology
FOUNDED – 2004
STAFF – 6

The company was founded in 2004.

People
Anna Langenius worked on the deal for ALMI Invest.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Nordics
• Healthcare
• Expansion
• Sweden